ARCHIVES

Phase II Study of Veliparib Improves PFS by 35 Percent

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NI Selects15 Cancer Patient Advocates for Director’s Consumer Liaison Group

November 23, 1997

DCPC Bard Approves Concepts For New Minority Enhancement Awards Program, Two RFA Reissues

January 22, 1988

Doctor’s Allegation Of Drug Safety Problem Starts Controversy With Manufacturer

May 5, 1995

NCA Urges Pay Line Adjustment To Cut Back On Grant Duplications

October 10, 1980

NCI Changes Deadlines For Two RFAS

July 18, 1997

Sentinel Node Disection No Worse Than Axillary

February 25, 2011